PI Industries Ltd (PIIND): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 5, 2025, 4:57 pm

Competitors of PI Industries Ltd (PIIND)

All Competitor Stocks of PI Industries Ltd (PIIND)

Quarterly Result

Last Updated: August 20, 2025, 5:35 am

Below is a detailed analysis of the quarterly data for PI Industries Ltd (PIIND) based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,900.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,787.00 Cr. (Mar 2025) to 1,900.00 Cr., marking an increase of 113.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,381.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,332.00 Cr. (Mar 2025) to 1,381.00 Cr., marking an increase of 49.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 519.00 Cr.. The value appears strong and on an upward trend. It has increased from 456.00 Cr. (Mar 2025) to 519.00 Cr., marking an increase of 63.00 Cr..
• For OPM %, as of Jun 2025, the value is 27.00%. The value appears strong and on an upward trend. It has increased from 25.00% (Mar 2025) to 27.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 14.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 96.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Mar 2025) to 96.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 507.00 Cr.. The value appears strong and on an upward trend. It has increased from 432.00 Cr. (Mar 2025) to 507.00 Cr., marking an increase of 75.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 21.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 400.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 400.00 Cr., marking an increase of 70.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 26.36. The value appears strong and on an upward trend. It has increased from 21.78 (Mar 2025) to 26.36, marking an increase of 4.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:18 pm

Growth

Last Updated: September 5, 2025, 12:15 pm

Balance Sheet

Last Updated: July 25, 2025, 2:35 pm

Below is a detailed analysis of the balance sheet data for PI Industries Ltd (PIIND) based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 10,142.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,716.00 Cr. (Mar 2024) to 10,142.00 Cr., marking an increase of 1,426.00 Cr..
• For Borrowings, as of Mar 2025, the value is 184.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 191.00 Cr. (Mar 2024) to 184.00 Cr., marking a decrease of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,908.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,822.00 Cr. (Mar 2024) to 1,908.00 Cr., marking an increase of 86.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 12,249.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,744.00 Cr. (Mar 2024) to 12,249.00 Cr., marking an increase of 1,505.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,209.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,528.00 Cr. (Mar 2024) to 4,209.00 Cr., marking an increase of 681.00 Cr..
• For CWIP, as of Mar 2025, the value is 550.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2024) to 550.00 Cr., marking an increase of 272.00 Cr..
• For Investments, as of Mar 2025, the value is 1,531.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,336.00 Cr. (Mar 2024) to 1,531.00 Cr., marking an increase of 195.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,959.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,601.00 Cr. (Mar 2024) to 5,959.00 Cr., marking an increase of 358.00 Cr..
• For Total Assets, as of Mar 2025, the value is 12,249.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,744.00 Cr. (Mar 2024) to 12,249.00 Cr., marking an increase of 1,505.00 Cr..

Notably, the Reserves (10,142.00 Cr.) exceed the Borrowings (184.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for PI Industries Ltd (PIIND), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 109.44. This value is within the healthy range. It has decreased from 110.85 (Mar 24) to 109.44, marking a decrease of 1.41.
• For Diluted EPS (Rs.), as of Mar 25, the value is 109.44. This value is within the healthy range. It has decreased from 110.83 (Mar 24) to 109.44, marking a decrease of 1.39.
• For Cash EPS (Rs.), as of Mar 25, the value is 132.13. This value is within the healthy range. It has increased from 130.21 (Mar 24) to 132.13, marking an increase of 1.92.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 668.22. It has increased from 574.41 (Mar 24) to 668.22, marking an increase of 93.81.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 668.22. It has increased from 574.41 (Mar 24) to 668.22, marking an increase of 93.81.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 524.86. It has increased from 504.33 (Mar 24) to 524.86, marking an increase of 20.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 166.00. This value is within the healthy range. It has increased from 146.21 (Mar 24) to 166.00, marking an increase of 19.79.
• For PBIT / Share (Rs.), as of Mar 25, the value is 142.81. This value is within the healthy range. It has increased from 125.93 (Mar 24) to 142.81, marking an increase of 16.88.
• For PBT / Share (Rs.), as of Mar 25, the value is 140.64. This value is within the healthy range. It has increased from 123.96 (Mar 24) to 140.64, marking an increase of 16.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 108.94. This value is within the healthy range. It has decreased from 109.93 (Mar 24) to 108.94, marking a decrease of 0.99.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 109.22. This value is within the healthy range. It has decreased from 110.63 (Mar 24) to 109.22, marking a decrease of 1.41.
• For PBDIT Margin (%), as of Mar 25, the value is 31.62. This value is within the healthy range. It has increased from 28.99 (Mar 24) to 31.62, marking an increase of 2.63.
• For PBIT Margin (%), as of Mar 25, the value is 27.20. This value exceeds the healthy maximum of 20. It has increased from 24.97 (Mar 24) to 27.20, marking an increase of 2.23.
• For PBT Margin (%), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 24.57 (Mar 24) to 26.79, marking an increase of 2.22.
• For Net Profit Margin (%), as of Mar 25, the value is 20.75. This value exceeds the healthy maximum of 10. It has decreased from 21.79 (Mar 24) to 20.75, marking a decrease of 1.04.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 20.81. This value exceeds the healthy maximum of 20. It has decreased from 21.93 (Mar 24) to 20.81, marking a decrease of 1.12.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.34. This value is within the healthy range. It has decreased from 19.25 (Mar 24) to 16.34, marking a decrease of 2.91.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.57. This value is within the healthy range. It has decreased from 21.14 (Mar 24) to 20.57, marking a decrease of 0.57.
• For Return On Assets (%), as of Mar 25, the value is 13.52. This value is within the healthy range. It has decreased from 15.62 (Mar 24) to 13.52, marking a decrease of 2.10.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has decreased from 0.79 (Mar 24) to 0.69, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 4.02. This value exceeds the healthy maximum of 3. It has increased from 3.90 (Mar 24) to 4.02, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 3.45. This value exceeds the healthy maximum of 2. It has increased from 3.14 (Mar 24) to 3.45, marking an increase of 0.31.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 6.98, marking an increase of 4.33.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.70. This value is below the healthy minimum of 20. It has increased from 10.37 (Mar 24) to 13.70, marking an increase of 3.33.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.30. This value is below the healthy minimum of 20. It has increased from 8.76 (Mar 24) to 11.30, marking an increase of 2.54.
• For Earning Retention Ratio (%), as of Mar 25, the value is 86.30. This value exceeds the healthy maximum of 70. It has decreased from 89.63 (Mar 24) to 86.30, marking a decrease of 3.33.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.70. This value exceeds the healthy maximum of 70. It has decreased from 91.24 (Mar 24) to 88.70, marking a decrease of 2.54.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 76.46. This value is within the healthy range. It has increased from 74.08 (Mar 24) to 76.46, marking an increase of 2.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 51.18. This value is within the healthy range. It has decreased from 56.70 (Mar 24) to 51.18, marking a decrease of 5.52.
• For Enterprise Value (Cr.), as of Mar 25, the value is 49,661.46. It has decreased from 56,230.52 (Mar 24) to 49,661.46, marking a decrease of 6,569.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.22. This value exceeds the healthy maximum of 3. It has decreased from 7.34 (Mar 24) to 6.22, marking a decrease of 1.12.
• For EV / EBITDA (X), as of Mar 25, the value is 19.68. This value exceeds the healthy maximum of 15. It has decreased from 25.30 (Mar 24) to 19.68, marking a decrease of 5.62.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.52. This value exceeds the healthy maximum of 3. It has decreased from 7.67 (Mar 24) to 6.52, marking a decrease of 1.15.
• For Retention Ratios (%), as of Mar 25, the value is 86.29. This value exceeds the healthy maximum of 70. It has decreased from 89.62 (Mar 24) to 86.29, marking a decrease of 3.33.
• For Price / BV (X), as of Mar 25, the value is 5.12. This value exceeds the healthy maximum of 3. It has decreased from 6.74 (Mar 24) to 5.12, marking a decrease of 1.62.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.52. This value exceeds the healthy maximum of 3. It has decreased from 7.67 (Mar 24) to 6.52, marking a decrease of 1.15.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness